Our analysis showed that after CIK/DC-CIK immunotherapy for CRC patients, IFN-γ and IL-2 levels were significantly increased, whereas no significant differences were observed in TNF-α and IL-6, indicating a more important role of Th1 than Th2 cytokines. The gene discussed is IL2; the disease is colorectal carcinoma.